TRAW Traws Pharma Inc.

Price (delayed)

$0.4881

Market cap

$7.4M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.71

Enterprise value

$4.26M

?
Relative Growth: Rel. Growth: 70
Relative Strength: Rel. Strength: 1
Relative Valuation: Rel. Valuation: 21
Relative Profitability: Rel. Profitability: 34

onconova therapeutics, inc. (nasdaq: ontx) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. using a proprietary chemistry platform, onconova has ...

Highlights
The EPS has soared by 93% YoY
Traws Pharma's net income has increased by 48% YoY
The equity has dropped by 189% year-on-year
The quick ratio has dropped by 84% year-on-year and by 29% since the previous quarter

Key stats

What are the main financial stats of TRAW

TRAW stock price

How has the Traws Pharma stock price performed over time
Intraday
-6.13%
1 week
-27.26%
1 month
-43.31%
1 year
-70.06%
YTD
-56.81%
QTD
-42.12%

Financial performance

How have Traws Pharma's revenue and profit performed over time
Revenue
$2.73M
Gross profit
$2.73M
Operating income
-$19.62M
Net income
-$14.75M
Gross margin
100%
Net margin
-539.7%
Traws Pharma's operating margin has soared by 99% YoY but it has decreased by 12% from the previous quarter
The net margin has soared by 96% YoY
The company's operating income has surged by 86% YoY but it fell by 10% QoQ
Traws Pharma's net income has increased by 48% YoY

Price vs fundamentals

How does TRAW's price correlate with its fundamentals

Growth

What is Traws Pharma's growth rate over time

Valuation

What is Traws Pharma stock price valuation
P/E
N/A
P/B
N/A
P/S
1.9
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.56
The EPS has soared by 93% YoY
The equity has dropped by 189% year-on-year
The price to sales (P/S) is 98% lower than the 5-year quarterly average of 80.3 and 60% lower than the last 4 quarters average of 4.8
The company's revenue fell by 2% QoQ

Efficiency

How efficient is Traws Pharma business performance
The ROS has soared by 96% YoY
TRAW's return on assets is up by 21% year-on-year

Dividends

What is TRAW's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TRAW.

Financial health

How did Traws Pharma financials performed over time
TRAW's total assets is 39% smaller than its total liabilities
The quick ratio has dropped by 84% year-on-year and by 29% since the previous quarter
The current ratio has plunged by 76% YoY and by 40% from the previous quarter
The debt is 100% more than the equity
The equity has dropped by 189% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.